31 – 40 of 62
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Intermediate prognosis in metastatic germ cell tumours—outcome and prognostic factors
(
- Contribution to journal › Article
-
Mark
A randomised study of tailored toxicity-based dosage of fluorouracil-epirubicin-cyclophosphamide chemotherapy for early breast cancer (SBG 2000-1)
(
- Contribution to journal › Article
- 2017
-
Mark
Societal challenges of precision medicine : Bringing order to chaos
(
- Contribution to journal › Article
-
Mark
Association of the oestrogen receptor beta with hormone status and prognosis in a cohort of female patients with colorectal cancer
(
- Contribution to journal › Article
-
Mark
Survival of patients with colorectal peritoneal metastases is affected by treatment disparities among hospitals of diagnosis : A nationwide population-based study
(
- Contribution to journal › Article
- 2016
-
Mark
No breast cancer subgroup can be spared postoperative radiotherapy after breast-conserving surgery. Fifteen-year results from the Swedish Breast Cancer Group randomised trial, SweBCG 91 RT
(
- Contribution to journal › Article
-
Mark
Long-term risk of renal and urinary tract diseases in childhood cancer survivors : A population-based cohort study
(
- Contribution to journal › Article
-
Mark
Challenging the dogma of colorectal peritoneal metastases as an untreatable condition : Results of a population-based study
(
- Contribution to journal › Article
- 2010
-
Mark
Lead-time in the european randomised study of screening for prostate cancer
(
- Contribution to journal › Article
-
Mark
On the use of prostate-specific antigen for screening of prostate cancer in European Randomised Study for Screening of Prostate Cancer
(
- Contribution to journal › Article